Decision Diagnostics Corp (DECN)

[loanranger]

Question #2:

2018 Issuances
"Common
During the quarter ended March 31, 2018, we issued 6,033,643 shares of $0.001 par value common stock for
conversion of debt and accrued interest totaling $615,432."

All of those shares were issued to Alpha Capital Anstalt and I wanted to try to find the terms of the notes in order to confirm the basis for the conversions, which averaged a little over a dime/share. So I went to the Balance sheet. It says "Notes payable and short term debt (Note 5)".
Unfortunately, and this has been pointed out many times before, Note 5 doesn't have anything to do with Notes ("NOTE 5 – Patents").
There are three(3) different reports submitted quarterly to OTCMarkets by DECN (Financials, Supplemental Info, Management Discussion) and this latest quarter's reports numbered a total of fifty nine(59) pages. Some information is needlessly duplicated and some important information isn't to be found. None of the 59 pages describes the terms of the Alpha Capital Anstalt notes that provided the basis of those conversions.
The line on the Balance Sheet that says "Notes payable and short term debt (Note 5)" reflects a balance of $1,580,295 as of 3/31/18. It is obviously the company's largest liability. Don't you think that it would be nice if the company would provide the detail that supports that balance instead of instead referring investors to the totally irrelevant "NOTE 5 – Patents"?